What Is The Long-Term Forecast For The Global Cardiac Troponin Market Growing At 10.3% CAGR?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Cardiac Troponin Market?
In recent times, the market size of cardiac troponin has seen a significant increase. The market that was valued at $3.85 billion in 2024 is projected to climb up to $4.24 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. This remarkable growth during the historic period can be credited to factors such as the increased incidence of cardiovascular issues, heightened awareness and early detection of heart ailments, advancements in healthcare infrastructure in developing markets, an ageing population, and the launch of high-sensitivity cardiac troponin tests.
Expansion is anticipated within the cardiac troponin market size, predicting a swift escalation within the next few years. By 2029, the market is projected to rise to $6.29 billion with a CAGR of 10.3%. This projected growth in the given period can be associated with an increase in lifestyle-related cardiovascular diseases’ occurrences, a broadening of cardiac care units in healthcare facilities, a surge in opting for home healthcare, personalized medicine expansion, and a demand for efficient and cost-effective diagnostic resolutions. Factors like the utilization of machine learning algorithms for data interpretation in cardiac care, a broadening of cardiac troponin applications beyond just acute coronary syndrome, advancements in mutiplex testing for simultaneous biomarker analysis, the development of new biomarkers in conjunction with troponin, and personalized medicine are also contributing key trends for the forecasted period.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18986&type=smp
What Are The Primary Factors Supporting The Cardiac Troponin Market Expansion?
The escalating instances of heart-related disorders are anticipated to spur the expansion of the cardiac troponin market in the future. Cardiovascular afflictions, like coronary artery disease, heart failure, arrhythmias, and congenital heart defects, which impact the heart’s structure and function, fall under heart-related disorders. The surge in prevalence of such conditions is prompted by elements including growing older population, inactive lifestyles, unhealthy eating habits, and increasing rates of obesity and hypertension. Cardiac troponin plays a pivotal role in diagnosing these disorders as it acts as a highly sensitive biomarker for identifying damage to heart muscles, particularly in heart attack cases and other cardiac episodes. For example, the Report on Registration of Births and Deaths 2023 published by the Registry of Births and Deaths, Immigration and Checkpoints Authority, Singapore and Ministry Of Health, reported the total number of deaths caused by ischemic heart diseases to be 5,302, showing a marginal rise from 5,290 reported in 2022. Therefore, the escalating instances of heart-related diseases will spur the expansion of the cardiac troponin market.
Which Segments Define The Structure Of The Cardiac Troponin Market?
The cardiac troponinmarket covered in this report is segmented –
1) By Type: Troponin I; Troponin T
2) By Location Of Testing: Laboratory Setting; Point Of Care (Poc) Testing
3) By Application: Acute Coronary Syndrome; Myocardial Infraction; Congestive Heart Failure; Other Applications
4) By End User: Hospitals; Diagnostic Centers; Homecare Setting; Other End Users
Subsegments:
1) By Troponin I: Cardiac Troponin I (cTnI); Muscle Troponin I
2) By Troponin T: Cardiac Troponin T (cTnT); Skeletal Troponin T
Which Disruptive Trends Are Driving Change Across The Cardiac Troponin Market?
Key players in the cardiac troponin market are emphasizing on the evolution of new technologies like human serum-based quality control for more precise and dependable high-sensitivity troponin testing by providing a range of multi-analyte controls. The utilization of human serum-based quality control in cardiac troponin testing enhances test dependability and precision by employing human serum with determined troponin levels to validate the assay’s efficacy. For instance, Bio-Rad Laboratories, Inc., a biotechnology research company based in the US, launched Cardiac Advance in May 2023. This is a multi-analyte quality control, created distinctly for high-sensitivity troponin testing, featuring four levels. They provide these controls, made of liquid human serum, in various formats including InteliQ 3-mL tubes, Liquichek 3-mL standard, and 2.5-mL compact bottles. These controls accommodate 10 cardiac analytes such as troponin, CK-MB, BNP/proBNP, and myoglobin, and are appropriate for utilization with Siemens and Roche testing apparatus. These products can be bought in the U.S., Europe, and specific Asian markets.
Who Are The Primary Market Leaders In The Cardiac Troponin Market?
Major companies operating in the cardiac troponin market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings (Labcorp), Zoetis Inc., bioMérieux SA, Beckman Coulter Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Radiometer Medical ApS, Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Meso Scale Diagnostics LLC., Singulex Inc., Diazyme Laboratories Inc., Response Biomedical Corporation, Eurolyser Diagnostica GmbH, LifeSign LLC
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/cardiac-troponin-global-market-report
What Regional Factors Are Accelerating Growth In The Cardiac Troponin Market?
North America was the largest region in the cardiac troponin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac troponin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=18986&type=smp
Browse Through More Reports Similar to the Global Cardiac Troponin Market 2025, By The Business Research Company
Cardiac Assist Devices And Equipment Global Market Report 2025
Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025
Cardiac Pacemakers Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
